Rice Hall James & Associates’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Rice Hall James & Associates’s Portfolio HPTX Stock Details HPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-89,916	Closed	-$4.13M	–	344
2015 Q1	$4.13M	Sell	89,916 -21,295	-19%	-$637K	0.24%	106
2014 Q4	$2.67M	Sell	111,211 -920	-0.8%	-$20.7K	0.16%	163
2014 Q3	$2.83M	Sell	112,131 -1,013	-0.9%	-$25.2K	0.2%	132
2014 Q2	$2.95M	Sell	113,144 -409	-0.4%	-$10.5K	0.2%	131
2014 Q1	$2.93M	Sell	113,553 -3,603	-3%	-$97.6K	0.22%	131
2013 Q4	$2.37M	Buy	117,156 +36,540	+45%	+$860K	0.17%	166
2013 Q3	$2.11M	Buy	+80,616	New	+$2.02M	0.2%	153

Rice Hall James & Associates's HPTX Position: Q2 2015 in Review

Rice Hall James & Associates sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 89,916 shares — an estimated $4.13M sold.

Rice Hall James & Associates first reported a position in HPTX in Q3 2013 and held it in 7 quarters. The position peaked at $4.13M in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

Rice Hall James & Associates reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Rice Hall James & Associates sold 89,916 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $4.13M.
Rice Hall James & Associates first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q3 2013 and held it in 7 quarters.
Rice Hall James & Associates's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $4.13M in Q1 2015.
0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Rice Hall James & Associates's 13F filing for Q2 2015, filed 31 Jul 2015.